DK1000035T3 - Substituerede 6-phenylphenanthridiner - Google Patents
Substituerede 6-phenylphenanthridinerInfo
- Publication number
- DK1000035T3 DK1000035T3 DK98943742T DK98943742T DK1000035T3 DK 1000035 T3 DK1000035 T3 DK 1000035T3 DK 98943742 T DK98943742 T DK 98943742T DK 98943742 T DK98943742 T DK 98943742T DK 1000035 T3 DK1000035 T3 DK 1000035T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- compounds
- phenylphenanthridines
- substituted
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97112793 | 1997-07-25 | ||
| PCT/EP1998/004478 WO1999005113A1 (fr) | 1997-07-25 | 1998-07-18 | 6-phenylphenanthridines substitues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1000035T3 true DK1000035T3 (da) | 2003-03-17 |
Family
ID=8227117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98943742T DK1000035T3 (da) | 1997-07-25 | 1998-07-18 | Substituerede 6-phenylphenanthridiner |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6121279A (fr) |
| EP (1) | EP1000035B1 (fr) |
| JP (1) | JP2001510827A (fr) |
| AT (1) | ATE228507T1 (fr) |
| AU (1) | AU756349B2 (fr) |
| CA (1) | CA2297911C (fr) |
| CZ (1) | CZ296064B6 (fr) |
| DE (1) | DE69809754T2 (fr) |
| DK (1) | DK1000035T3 (fr) |
| EE (1) | EE04189B1 (fr) |
| ES (1) | ES2189235T3 (fr) |
| HU (1) | HUP0003311A3 (fr) |
| IL (1) | IL133825A (fr) |
| PL (1) | PL191094B1 (fr) |
| PT (1) | PT1000035E (fr) |
| WO (1) | WO1999005113A1 (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1147089T3 (da) * | 1999-01-15 | 2006-04-10 | Altana Pharma Ag | Phenylphenanthridiner med PDE-IV-inhiberende virkning |
| DK1147087T3 (da) | 1999-01-15 | 2005-09-05 | Altana Pharma Ag | Phenanthridin-N-oxider med PDE-IV-inhiberende aktivitet |
| JP2002534507A (ja) | 1999-01-15 | 2002-10-15 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 新規６−アリールフェナントリジン |
| ATE356810T1 (de) | 1999-01-15 | 2007-04-15 | Altana Pharma Ag | Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung |
| US6495550B2 (en) * | 1999-08-04 | 2002-12-17 | Icagen, Inc. | Pyridine-substituted benzanilides as potassium ion channel openers |
| NZ516610A (en) | 1999-08-04 | 2004-05-28 | Icagen Inc | Benzanilides as potassium channel openers |
| PT1212089E (pt) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
| WO2001051470A1 (fr) * | 2000-01-11 | 2001-07-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridine-n-oxydes |
| WO2002005616A1 (fr) * | 2000-07-14 | 2002-01-24 | Altana Pharma Ag | Nouvelles 6-phenylphenanthridines |
| DK1303506T3 (da) | 2000-07-14 | 2005-05-30 | Altana Pharma Ag | 6-heteroarylphenanthridiner |
| EP1458679B1 (fr) | 2001-12-20 | 2010-01-20 | Merck Serono SA | Derives de pyrrolidine utilises en tant que modulateurs de la prostaglandine |
| EP1537086A2 (fr) * | 2002-08-17 | 2005-06-08 | ALTANA Pharma AG | Nouvelles phenanthridines |
| JP4587294B2 (ja) | 2002-08-29 | 2010-11-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４インヒビターとしての２−ヒドロキシ−６−フェニルフェナントリジン |
| ATE353217T1 (de) * | 2002-08-29 | 2007-02-15 | Altana Pharma Ag | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren |
| US6894061B2 (en) * | 2002-12-04 | 2005-05-17 | Wyeth | Substituted dihydrophenanthridinesulfonamides |
| CA2533636A1 (fr) * | 2003-07-31 | 2005-02-10 | Altana Pharma Ag | Nouvelles 6-phenylphenanthridines |
| EP1658270A1 (fr) * | 2003-07-31 | 2006-05-24 | ALTANA Pharma AG | Nouvelles 6-phenylphenanthridines |
| AU2005212857B2 (en) * | 2004-02-18 | 2011-04-28 | Takeda Gmbh | Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| CN104817534A (zh) | 2004-03-03 | 2015-08-05 | 塔科达有限责任公司 | 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途 |
| EP1745025A2 (fr) * | 2004-03-09 | 2007-01-24 | Altana Pharma AG | Nouveaux dérivés hydroxy-6-phenylphenanthridine substitué par un groupe isoamido et leur utilisation comme inhibiteurs de pde4 |
| EP1725532A1 (fr) * | 2004-03-10 | 2006-11-29 | Altana Pharma AG | Nouveaux dérivés hydroxy-6-phénylphénanthridine substitué par un groupe difluoroéthoxy et leur utilisation comme inhibiteurs de pde4 |
| US20070185149A1 (en) * | 2004-03-10 | 2007-08-09 | Altana Pharma Ag | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors |
| CA2558390A1 (fr) * | 2004-03-10 | 2005-09-22 | Altana Pharma Ag | Nouvelles hydroxy-6-phenylphenanthridines contenant thio et leur utilisation comme inhibiteurs de pde4 |
| WO2006092422A1 (fr) | 2005-03-02 | 2006-09-08 | Nycomed Gmbh | Nouveaux sels de derives d’hexahydrophenanthridine substitues par des groupements 6-heterocyclyles |
| CA2599368A1 (fr) * | 2005-03-09 | 2006-09-14 | Nycomed Gmbh | 6-phenylphenanthridines amido-substituees |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP2258358A3 (fr) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenèse avec un inhibiteur de l'acetylcholinestérase |
| EP1940389A2 (fr) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation de la neurogenese par inhibition de la pde |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| JP2010502722A (ja) | 2006-09-08 | 2010-01-28 | ブレインセルス，インコーポレイティド | ４−アシルアミノピリジン誘導体を含む組み合わせ |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| JP5187616B2 (ja) | 2007-07-31 | 2013-04-24 | 住友化学株式会社 | β−ニトロスチレン化合物の製造方法 |
| WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
| US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309545A (en) * | 1980-07-28 | 1982-01-05 | Pfizer Inc. | Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof |
| EA001205B1 (ru) * | 1996-01-31 | 2000-12-25 | Бык Гульден Ломберг Хемише Фабрик Гмбх | Новые фенантридины |
| EP0889886B1 (fr) * | 1996-03-26 | 2002-09-18 | ALTANA Pharma AG | Nouvelles phenanthridines substituees en position 6 |
| GB9606425D0 (en) * | 1996-03-27 | 1996-06-05 | Binding Site Ltd | Improvements in and relating to the production of antibodies and test kits incorporating antibodies |
-
1998
- 1998-07-18 WO PCT/EP1998/004478 patent/WO1999005113A1/fr active IP Right Grant
- 1998-07-18 US US09/462,508 patent/US6121279A/en not_active Expired - Fee Related
- 1998-07-18 CA CA002297911A patent/CA2297911C/fr not_active Expired - Fee Related
- 1998-07-18 AT AT98943742T patent/ATE228507T1/de not_active IP Right Cessation
- 1998-07-18 PL PL338452A patent/PL191094B1/pl not_active IP Right Cessation
- 1998-07-18 AU AU91546/98A patent/AU756349B2/en not_active Ceased
- 1998-07-18 EP EP98943742A patent/EP1000035B1/fr not_active Expired - Lifetime
- 1998-07-18 DE DE69809754T patent/DE69809754T2/de not_active Expired - Fee Related
- 1998-07-18 JP JP2000504112A patent/JP2001510827A/ja not_active Withdrawn
- 1998-07-18 PT PT98943742T patent/PT1000035E/pt unknown
- 1998-07-18 IL IL13382598A patent/IL133825A/en not_active IP Right Cessation
- 1998-07-18 HU HU0003311A patent/HUP0003311A3/hu unknown
- 1998-07-18 EE EEP200000032A patent/EE04189B1/xx not_active IP Right Cessation
- 1998-07-18 ES ES98943742T patent/ES2189235T3/es not_active Expired - Lifetime
- 1998-07-18 CZ CZ20000281A patent/CZ296064B6/cs not_active IP Right Cessation
- 1998-07-18 DK DK98943742T patent/DK1000035T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| AU756349B2 (en) | 2003-01-09 |
| ES2189235T3 (es) | 2003-07-01 |
| HUP0003311A2 (en) | 2001-03-28 |
| CZ296064B6 (cs) | 2006-01-11 |
| IL133825A (en) | 2005-12-18 |
| PL191094B1 (pl) | 2006-03-31 |
| EE200000032A (et) | 2000-10-16 |
| PL338452A1 (en) | 2000-11-06 |
| HUP0003311A3 (en) | 2002-10-28 |
| US6121279A (en) | 2000-09-19 |
| DE69809754D1 (en) | 2003-01-09 |
| AU9154698A (en) | 1999-02-16 |
| ATE228507T1 (de) | 2002-12-15 |
| DE69809754T2 (de) | 2003-09-18 |
| CA2297911C (fr) | 2007-09-04 |
| CA2297911A1 (fr) | 1999-02-04 |
| EP1000035B1 (fr) | 2002-11-27 |
| EP1000035A1 (fr) | 2000-05-17 |
| EE04189B1 (et) | 2003-12-15 |
| PT1000035E (pt) | 2003-04-30 |
| CZ2000281A3 (cs) | 2000-08-16 |
| JP2001510827A (ja) | 2001-08-07 |
| WO1999005113A1 (fr) | 1999-02-04 |
| IL133825A0 (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE228507T1 (de) | Substituierte 6-phenylphenanthridine | |
| DK0889886T5 (da) | Hidtil ukendte, i 6-stilling substituerede phenanthridiner | |
| TR200103186T2 (tr) | MEK enzimlerinin inhibitörleri olarak kinolin türevleri | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| EE200000033A (et) | Uudsed tetrasoolderivaadid | |
| BR9707233A (pt) | Fenantridinas | |
| FI970148A (fi) | Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
| ES2175079T3 (es) | Derivados de indol utiles como inhibidores de cgmp-pde. | |
| DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
| PT920426E (pt) | Novos derivados de tiazole com efeito inibidor de fosfodiesterase | |
| ES2135769T3 (es) | Derivados de isotiourea como inhibidores de no-sintasa. | |
| ES2249309T3 (es) | Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa. | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| SI1377574T1 (fr) | ||
| HUP0100781A2 (hu) | A jóindulatú prosztata hiperplázia kezelésére alkalmas szubsztituált piridino aril piperazin-származékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
| TR199903159T2 (xx) | Yeni �-Amino ve �-Azido karbonik asit t�revleri. | |
| ATE247649T1 (de) | Disubstituierte biphenyloxazoline | |
| ZA955052B (en) | Pyrrolidine derivatives their preparation and compositions containing them | |
| IL139317A0 (en) | Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same |